[New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000097:blood / Q000188:drug therapy*; D051381:Rats; D001748:Urinary Bladder Neck Obstruction / Q000097:blood / Q000188:drug therapy*; D014563:Urodynamics / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; C041226:Terazosin; D011224:Prazosin